TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07311876: Clinical Lymphedema Evaluation - Advancing Reconstruction of Head and Neck Lymphatics With Symani

Sponsor: MMI (Medical Microinstruments, Inc.) · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 30 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$8,466,000

Rescue Site Savings

+$5,577,600

Unlock Full NCT07311876 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07311876 Rescue Dossier →